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Abnormal behavior such as catalepsy, walking backwards and pivoting was also observed. 49-THC failed to inhibit the pressor responses to electrical stimulation of the posterior hypothalamus and midbrain reticular formation, whereas the drug suppressed the behavioral responses to stimulation of both regions. It is concluded that the cardiovascular effects seen with 49-THC injection are mainly the result of alteration of the efferent vagal activity by acting on the central nervous system and a more potent influence is exerted on the behavioral changes than on autonomic responses to brain stimulation.
Cardiovascular effects of delta-9-tetrahydrocannabinol (49-THC), the major psycho active constituent of marijuana, have been well documented in the rat (1-3), cat (4-6), dog (7) (8) (9) and man (10, 11) . The results obtained in these experiments demonstrate that 49 THC induces a hypotension and bradycardia in animals, although heart rate in humans usually increases. Cavero et al. (8) reported that 49-THC acted on the central nervous system and produced a decrease in heart rate as a result of the enhancement of vagal activity.
They also suggested (7) that the hypotension induced by J9-THC was due to a reduction in cardiac output resulting from decreased heart rate.
On the other hand, Vollmer et al. (6) demonstrated that d9-THC produced cardiovascular alterations by a central action resulting in a decrease in sympathetic tone.
Although there is general agreement that the site of action of d9-THC is in the central nervous system, the underlying neural mechanisms involved in cardiovascular alterations by 49-THC remain unknown.
As for the central action of 49-THC, it was reported that 49-THC depressed the pressor response induced by electrical stimulation of sympathetic areas such as the hypothalamus and medulla (4, 5) . However, most of these experiments were performed on anesthetized animals. Recently, Jandhyala and Buckley (12) emphasized that various anesthetic agents exerted considerable influence on the cardiovascular effects of 49-THC.
We investigated the effect of 49-THC on the cardiovascular system and also on the pressor and behavioral responses to brain stimulation in conscious, freely moving rats and our findings are reported herein.
MATERIALS AND METHODS
Animals: Male Wistar King A rats weighing between 280-300 g, from Kyushu Uni versity Institute of Laboratory Animals, were used. All animals were provided food and water ad libitum and housed in an air conditioned room with a 12 hr light/dark cycle (lights on at 08:00). After arterial cannula implantation, the animals were transferred to individual cages.
Experiments in anesthetized rats: The animals were anesthetized with urethane (1. (14) . The remainder was led beneath the skin to emerge at the incision at the head. A reference electrode made of the same stainless steel wire was placed on the skull.
Each electrode was soldered to a connector socket and all exposed parts of the electrodes and connector socket itself were fixed on the skull with two screws and dental cement.
After the operation 100,000 units of procaine penicillin G were given i.m. A 10 day recovery period was then allowed. For chronic cannula implantation, the animal was anesthetized with ether. One end of a cannula (PE10), composed of thin polyethylene tubing (PE10 and PE20), was inserted into the abdominal aorta via the left femoral artery. The other end (PE20) was passed beneath the skin to the incision at the dorsum of neck, where it was exteriorized for a distance of 2 cm and lightly anchored to the surrounding tissue with fine sutures. The arterial cannula was previously filled with heparinized saline (500 units/ml) and plugged with a stainless steel stopper. The complete procedure for the construction and implantation of the arterial cannula was described in our previous report (15) . Concomitant with this surgery, a cannula for drug administration, composed of thin polyethylene tubing (PE10 and PE20), was also chronically implanted into the abdominal cavity. The remainder was passed beneath the skin to the neck insicion, exteriorized for a distance of 2 cm, and fixed to the surrounding tissue together with the arterial cannula. After the operation, 100,000 units of procaine penicillin G were given i.m. To prevent the exposed part of the cannula from being bitten off by other rats, the animals were housed individually. A recovery period of 4 days after the operation was allowed prior to experimentation.
Blood pressure and heart rate in freely moving rats were measured as described previously (14) . The arterial cannula stopper was removed and the cannula was attached to a piece of polyethylene tubing connected with a Toyo Socki pressure transducer
Arterial blood pressure was measured by a San-ei Socki bio physiograph (SYS-180) via the transducer. The diastolic pressure plus one-third pulse pressure was regarded to be mean blood pressure. Heart rate was measured as beats/min by a Nihon Koden cardiotachograph (RT-5) triggered by ECG which was amplified with a San-ei Socki biophysiograph (SYS-180). Blood pressure and heart rate were simultaneously recorded on a San-ei Socki rectigraph (8S).
The lead wire for electrical stimulation of the brain was connected to the connector socket on the animal's head. Electrical stimulation was applied through a Nihon Koden (MSE-3R) electronic stimulator. After connecting the cannula and lead wire, the animal was transferred to an open-topped plexiglass cage, which was placed in a sound-proof box.
Arterial blood pressure and heart rate were measured while observing the behavior of the rat through the window of the sound-proof box. After the animal adapted itself to the cage and was calm, PH and MRF were electrically stimulated. Square wave pulses (1.0 msec, 50 Hz) were applied for 5 seconds. The stimulus voltage was increased until steady optimal responses were obtained.
Drugs: Drugs used in the present experiment were as follows: 49-THC (extracted from cannabis in the Dept. of Pharmacognosy, Kyushu Univ.) and atropine sulphate (Merck).
49-THC was emulsified in 1 % Tween 80 and the emulsion was diluted in 0.9 % saline. In experiments on anesthetized rats, all drugs were diluted with saline and given i.v. In freely moving rats, drugs were administered through the chronically implanted abdominal cannula.
The cannula was attached to a polyethylene tubing extension (PE20) which had been pre viously filled with saline. The other end of the tubing was led to the outside of the sound proof box. The assigned drug was given i.p. through this tubing making it unnecessary to touch the animal. After every administration, the tubing was flushed with saline.
Statistical analysis: Student's t-test was used for statistical analysis.
Histology: After completion of the experiment, the animals were anesthetized with ether and the brains were perfused with 10% formalin. The brain was removed, fixed, prepared into 50j frozen sections, and stained with cresyl violet. Electrode placement was verified histologically. Experiments in freely moving rats a) Cardiovascular responses and behavioral changes induced by d 9-THC: When the rat with chronic electrodes and cannula implants was transferred to the plexiglass cage from the home cage, marked exploratory behavior such as rearing, sniffing and searching was observed, and the mean blood pressure and heart rate were high and unstable. Thereafter, as exploratory behavior decreased, mean blood pressure and heart rate gradually fell. Thirty min after being transferred to the plexiglass cage, the rat became calm and continued to sit in one corner of the cage. During this period, mean blood pressure and heart rate were low and very stable. Intraperitoneal administration of 49-THC was given through the abdominal cannula without touching the rat and while the animal maintained a sitting posture. Figures 2 and 3 indicate changes in the mean blood pressure and heart rate follow ing the administration of 49-THC in freely moving rats. Neither mean blood pressure nor heart rate was altered by the administration of vehicle (1 % Tween 80-saline 1 ml/kg) (Fig. 2) .
49-THC in doses of 4 and 6 mg/kg but not 8 mg/kg produced a significant dose-related rise in blood pressure (Fig. 3B) . The maximal pressor response was observed within 2-3 min following 49-THC and the action lasted for 10-20 min. However, a fall in blood pressure following the pressor response was not seen for 120 min after 49-THC administration.
A transient fall of 50-60 mm Hg in blood pressure was observed within 1 min after adminis tration of 49-THC in a dose of 8 mg/kg (Fig. 2) . At this period, the animal frequently exhibited a writhing syndrome. 49-THC in doses of 4, 6 and 8 mg/kg caused a significant reduction in heart rate lasting over 120 min (Fig. 3A) . The bradycardia appeared gradually, and became maximum between 10-60 min after administration of 49-THC.
49-THC in doses of 4, 6 and 8 mg/kg reduced spontaneous locomotor activity of the rat and ataxia occurred within 10 min after administration. After this period, all animals continuously showed catalepsy and such abnormal and unusual behavior as suddenly walking backwards, pivoting and heterophasia. This abnormal behavior occurred most frequently about 30 min after 49-THC administration and lasted for 120 min. Although the blood pressure and heart rate were stable during cataleptic state, during the abnormal behavior, both blood pressure and heart rate was immediately elevated. Even when the animal stopped moving, elevated blood pressure and/or heart rate persisted and gradually returned to baseline levels after 5 min. During this period, the animals became more aggressive and irritable, and violently vocalized when their back was touched. On the other hand, a hypotensive action of 49-THC was not seen in the conscious rat and only a slight fall in blood pressure occurred with the highest dose of 49-THC in the anesthetized rat. It has been reported that 49-THC produced a significant and gradual fall in blood pressure in anesthetized rats, cats and dogs. Vollmer et al. (6) proposed that the hypotensive action of 49-THC was mainly due to a decrease in sympathetic tone, since the spontaneous discharges in the inferior cardiac nerve were reduced by 49-THC in the anesthetized cat. In the anesthetized rat, we found that the slight fall in blood pressure seen after a high dose of 49-THC returned to control level concomitant with the antagonism of 49-THC-induced bradycardia by atropine. Therefore, as suggested by Cavero et al. (7), the hypotensive action of 49-THC may be due in part to a reduction in cardiac output as a result of the decrease in heart rate. There has been no evidence that 49-THC has a direct effect on the contractile properties of the myocardium (7, 9) . On the other hand, in the conscious rat, a decline in blood pressure was not observed after 49-THC treatment, although the heart rate was significantly reduced. Thus, the contribution of reduced cardiac output amygdala and posterior hypothalamus in the monkey. Based on these facts, it is con ceivable that 49-THC acts more strongly on behavioral rather than autonomic responses to brain stimulation. We have reported that psychotropic drugs such as chlorpromazine, diazepam and imipramine little suppressed the behavioral changes to both PH and MRF stimulation in the conscious rat, even when the pressor response was markedly inhibited by these drugs (15) . It is interesting that 49-THC suppresses the behavioral changes to brain stimulation with less influence on the pressor response, while psychotropic agents have a more potent inhibitory effect on pressor response than that on behavioral changes to brain stimulation.
In conclusion, the present results suggest that the cardiovascular responses to 49-THC are mainly due to an increase in vagal activity and that 49-THC exerts a more potent influence on behavioral responses than on autonomic responses to brain stimulation.
